# Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy Adults

> **NCT04059978** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 21 (actual)

## Conditions studied

- Acute Nociceptive Pain
- Hyperalgesia
- Allodynia
- Opioid-induced Hyperalgesia

## Interventions

- **DRUG:** CBD
- **DRUG:** Placebo
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT04059978
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-26
- **Primary completion:** 2020-10-15
- **Final completion:** 2020-10-15
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04059978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04059978, "Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04059978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*